000 01057 a2200301 4500
005 20250516094940.0
264 0 _c20121016
008 201210s 0 0 eng d
022 _a1873-2518
024 7 _a10.1016/j.vaccine.2011.09.061
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aO'Hagan, D T
245 0 0 _aThe mechanism of action of MF59 - an innately attractive adjuvant formulation.
_h[electronic resource]
260 _bVaccine
_cJun 2012
300 _a4341-8 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdjuvants, Immunologic
_xadministration & dosage
650 0 4 _aAnimals
650 0 4 _aHumans
650 0 4 _aInfluenza Vaccines
_xadministration & dosage
650 0 4 _aPolysorbates
_xadministration & dosage
650 0 4 _aSqualene
_xadministration & dosage
700 1 _aOtt, G S
700 1 _aDe Gregorio, E
700 1 _aSeubert, A
773 0 _tVaccine
_gvol. 30
_gno. 29
_gp. 4341-8
856 4 0 _uhttps://doi.org/10.1016/j.vaccine.2011.09.061
_zAvailable from publisher's website
999 _c21850234
_d21850234